Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > New Interview with Dr. McFarland - Fort Worth Report

<< Previous

Bullboard Posts

Next >>

Comment by skys1on Mar 15, 2022 3:59pm

225 Views

Post# 34516296

RE:New Interview with Dr. McFarland - Fort Worth Report

Thanks Eoganacht, this is the best interview I have seen with Dr Sherri. "Virtually no side effects". There is, " No standard of Care" that exists for these bladder cancer patients. Some great quotes. After reading this there aren't many questions left to ask.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)